FDA Approves Med-El Cochlear Implant for Children 7 Months and Older
The FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
The FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
NAL-NL3 is a modernized, modular update to the long-standing NAL-NL2 prescription, designed to better support individual hearing needs.
A recent study of outcomes in infants and young deaf children with cochlear implants suggests that socioeconomic status plays a major role in whether spoken language becomes their primary communication mode.
The newly released Counseling-Infused Audiologic Care offers a practical, person-centered guide to audiologic counseling rooted in evidence-based practice.
Frank Lin, MD, PhD, discusses the Know Your Hearing Number campaign and why this concept can help break down barriers to hearing care.Â
Oticon and Henry Ford Health's Division of Audiology launched a clinical research partnership to improve hearing aid fittings.
Angela Bonino, PhD, discusses her research on the lack of access to adequate hearing assessments for children with developmental disabilities.